Comparative Clinical Trial of Antibodies to Interferon-Gamma (IFN-γ) and Tumor Necrosis Factor-Alpha (TNF-α) in the Treatment of Rheumatoid Arthritis

Journal of Immune Based Therapies, Vaccines and Antimicrobials
doi 10.4236/jibtva.2015.41001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2012English

Tumor Necrosis Factor-Α Blockade Treatment Decreased CD154 (CD40-ligand) Expression in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2017English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy
2014English

Pleural Fluid Interferon-Γ and Tumour Necrosis Factor-Α in Tuberculous and Rheumatoid Pleurisy

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1996English

Role of Secreted Frizzled-Related Protein 1 and Tumor Necrosis Factor-Α (TNF-α) in Bone Loss of Patients With Rheumatoid Arthritis

International Journal of Rheumatology
RheumatologyImmunology
2020English

Gamma Interferon and Lipopolysaccharide Interact at the Level of Transcription to Induce Tumor Necrosis Factor Alpha Expression

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2001English

The Role of Cytokines in Predicting the Effectiveness of Combined Treatment With Tumor Necrosis Factor Α Inhibitors in Rheumatoid Arthritis

2018English

NF-κB; IL-1β; Tumor Necrosis Factor-Α (TNF-α)

Science-Business eXchange
2009English

IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS

TURKISH MEDICAL STUDENT JOURNAL
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy